WeVote
Log In

Bill

Bill

SR 851

Georgia Senate; creation of a life sciences caucus; encourage

2025-2026 Regular Session Introduced by Drew Echols and 7 co-sponsors

Georgia Senate creates a Life Sciences Caucus to coordinate legislative policy supporting biotech, pharmaceuticals, and medical device industries.

Senate Read and Referred
0
WeVote Research Nonpartisan
Bill Summary · SR 851

Legislative bill overview

SR 851 creates a formal Life Sciences Caucus within the Georgia Senate to promote coordination and advocacy around life sciences industries and related policy matters. The resolution establishes a legislative working group focused on biotechnology, pharmaceuticals, medical devices, and related sectors within the state.

Why is this important

Georgia has growing biotech and life sciences sectors, particularly around Atlanta and research institutions. A dedicated caucus can coordinate legislative efforts to support industry development, workforce training, tax incentives, and regulatory frameworks that affect competitiveness in this high-value economic sector.

Potential points of contention

  • Resource allocation: Critics may question whether creating new legislative caucuses diverts attention and resources from other policy priorities during budget constraints.
  • Industry favoritism: Some may argue that establishing a dedicated caucus gives outsized influence to life sciences lobbies compared to other important economic sectors.
  • Specificity concerns: The resolution lacks detail on the caucus's specific mandate, funding, staffing, or measurable goals, potentially creating an unfocused initiative.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.